Get the Stockscreener App
1.11
3.48%
-0.04
After Hours:
1.11
Biovie Inc stock is traded at $1.11, with a volume of 125.38K.
It is down -3.48% in the last 24 hours and down -11.90% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.15
Open:
$1.16
24h Volume:
125.38K
Relative Volume:
1.30
Market Cap:
$8.37M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.2135
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
+4.72%
1M Performance:
-11.90%
6M Performance:
-33.53%
1Y Performance:
-35.84%
1-Day Range:
$1.08
$1.19
1-Week Range:
$1.08
$1.21
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.11 | 8.67M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting - bitget.com
Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... - Proactive financial news
Alzheimer's and Long COVID research heads to 2026 psychiatry meeting - Stock Titan
BioVie highlights bezisterim research at ACP meeting - Proactive financial news
BioVie could offer first new Parkinson’s therapy in decades - Yahoo! Finance Canada
EV Market: Is BioVie Inc a turnaround storyQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - Milwaukee Journal Sentinel
Key facts: BioVie Inc. reports $6.1M Q4 loss; faces operational issues - TradingView
BIOVIE INC. SEC 10-Q Report - TradingView
BIVI: Net loss narrowed, cash bolstered by $10.5M raise, but going concern risks persist - TradingView
Aug Sentiment: Will BioVie Inc stock go up in YEARTrade Entry Report & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Setup Watch: Will BioVie Inc stock go up in YEARWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Trading Recap: What are the analyst revisions for BioVie IncIs Olympic Steel Inc stock a good investment in YEARForecast Cut & Short-Term High Return Ideas - baoquankhu1.vn
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - Foster's Daily Democrat
Aug Mood: Is BioVie Inc. forming a bullish divergenceJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - mfd.ru
Option Therapeutics files for IPO of 2.3 million shares of common stockSEC filing - marketscreener.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - accessnewswire.com
Can BioVie Inc. stock sustain free cash flow growthJuly 2025 Highlights & Target Return Focused Picks - Bollywood Helpline
Short Covering: Will BioVie Inc outperform the market in YEARWeekly Trade Summary & Daily Momentum Trading Reports - baoquankhu1.vn
BioVie hits enrolment milestone in early Parkinson’s trial, data due later this year - Proactive financial news
BioVie (NASDAQ:BIVI) Stock Price Down 4.7% – Should You Sell? - Defense World
BioVie | 4: Statement of changes in beneficial ownership of securities-Officer Palumbo Joseph M - 富途牛牛
BioVie completes enrollment for Parkinson’s drug trial By Investing.com - Investing.com Nigeria
Is Biovie's SUNRISE-PD The First Light Of Change In Early Parkinson's? - RTTNews
Why BioVie Inc. stock is rated strong buyJuly 2025 Short Interest & Fast Moving Trade Plans - Улправда
Will BioVie Inc. stock benefit from infrastructure spendingWeekly Profit Summary & Technical Pattern Based Buy Signals - ulpravda.ru
Is BioVie Inc. stock cheap compared to fundamentalsJuly 2025 Outlook & Safe Entry Point Identification - Улправда
Why retail investors pile into BioVie Inc. stockQuarterly Profit Review & Safe Capital Investment Plans - Улправда
Will BioVie Inc. stock see insider buyingMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
Stock Analysis: How supply chain issues affect BioVie Inc. stockNew Guidance & Fast Exit Strategy with Risk Control - Улправда
BioVie completes enrollment for Parkinson’s drug trial - Investing.com
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease - GlobeNewswire
Is BioVie Inc. stock dividend yield sustainableSmall Cap Stock Opportunities & Affordable Market Insights - Улправда
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - sctimes.com
Aug Shorts: Why BioVie Inc stock is rated strong buyWeekly Stock Analysis & High Accuracy Trade Signal Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
BioVie (NASDAQ:BIVI) Trading Down 5.8% – What’s Next? - Defense World
BioVie Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Real-Time Stock Market Data - earlytimes.in
Will BioVie Inc. stock outperform Dow Jones indexJuly 2025 Snapshot & Fast Gain Stock Trading Tips - ulpravda.ru
BioVie advances lead drug candidatesICYMI - Proactive financial news
Breakout Zone: Will BioVie Inc. stock outperform Dow Jones indexJobs Report & Reliable Price Breakout Alerts - Улправда
What Wall Street predicts for BioVie Inc. stock priceMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):